13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
90 檔
39.4%
At the close of Q1 2026, Knott David M Jr disclosed equity holdings valued at approximately $189.2M, spread across 90 reported holdings.
Knott David M Jr executed strategic sector rebalancing during Q1 2026, establishing 10 new positions while fully exiting 12 holdings and trimming 13 positions.
In terms of portfolio concentration, the top 5 core holdings (including GOOG, APO, SNDX) accounted for 39.4% of total reported equity market value during Q1 2026.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 15.61% | +1.46% | — | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 14.92% | -0.85% | — | |
| 3 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 5.87% | -0.82% | +1.69% | |
| 4 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 3.98% | -0.32% | +5.88% | |
| 5 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 3.95% | +0.13% | -13.70% | |
| 6 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 3.66% | +0.78% | +9.28% | |
| 7 | JPM | Jpmorgan Chase & Co | Stock-Financials | 3.41% | -0.28% | — | |
| 8 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 3.34% | +0.18% | — | |
| 9 | ✓ | LPL Financial Holdings Inc. | Stock-Other | 2.95% | -0.49% | — | |
| 10 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 2.80% | -0.30% | — | |
| 11 | ALKS | Alkermes plc | Stock-Healthcare | 2.53% | +0.84% | +26.32% | |
| 12 | TVTX | Travere Therapeutics Inc | Stock-Other | 2.49% | +1.93% | -24.39% | |
| 13 | COGT | Cogent Biosciences Inc | Stock-Other | 2.38% | -0.11% | +1.96% | |
| 14 | VRDN | Viridian Therapeutics Inc | Stock-Other | 2.11% | -0.35% | +24.83% | |
| 15 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 1.87% | -0.01% | +416.99% | |
| 16 | RLMD | Relmada Therapeutics Inc | Stock-Other | 1.82% | -0.17% | — | |
| 17 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 1.78% | +0.16% | +100.00% | |
| 18 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.77% | -1.77% | EXIT | |
| 19 | ACLXGBX | Arcellx Inc | Stock-Other | 1.33% | -1.33% | EXIT | |
| 20 | ✓ | Stock-Other | 1.33% | — | -24.39% | ||
| 21 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 1.14% | +0.11% | +15.38% | |
| 22 | AB | Alliancebernstein Holding LP | Stock-Other | 1.07% | -0.18% | — | |
| 23 | RCUS | Arcus Biosciences Inc | Stock-Other | 1.04% | +0.28% | -32.99% | |
| 24 | DCGO | Docgo Inc | Stock-Other | 1.00% | -0.27% | — | |
| 25 | HELP | Cybin Inc | Stock-Other | 1.00% | +0.29% | +22.73% | |
| 26 | CYTK | Cytokinetics Inc | Stock-Healthcare | 0.93% | -0.93% | EXIT | |
| 27 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.92% | -0.92% | EXIT | |
| 28 | ATRC | Atricure Inc | Stock-Other | 0.87% | -0.11% | — | |
| 29 | ARDX | Ardelyx Inc | Stock-Other | 0.74% | -0.03% | — | |
| 30 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 0.73% | -0.06% | — | |
| 31 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.72% | -0.06% | -28.89% | |
| 32 | RZLT | Rezolute Inc | Stock-Other | 0.67% | +0.35% | +8.82% | |
| 33 | OBIO | Orchestra Biomed Holdings In | Stock-Other | 0.64% | -0.06% | +1.46% | |
| 34 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.62% | +0.23% | — | |
| 35 | VERA | Vera Therapeutics Inc | Stock-Other | 0.62% | -0.03% | — | |
| 36 | ✓ | Connect Biopharma Hldgs LTD | Stock-Other | 0.60% | -0.04% | +93.92% | |
| 37 | IBB | Ishares Biotechnology ETF | ETF-Tech | 0.55% | — | — | |
| 38 | PFE | Pfizer Inc | Stock-Healthcare | 0.54% | -0.13% | — | |
| 39 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.49% | -0.43% | -38.08% | |
| 40 | CNQ | Canadian Natural Resources | Stock-Energy | 0.49% | -0.14% | — | |
| 41 | BIIB | Biogen Inc | Stock-Healthcare | 0.44% | +0.02% | -33.33% | |
| 42 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.41% | +0.26% | +65.30% | |
| 43 | AAPL | Apple Inc | Stock-Tech | 0.38% | — | — | |
| 44 | MSFT | Microsoft CORP | Stock-Tech | 0.35% | -0.03% | — | |
| 45 | VSTM | Verastem Inc | Stock-Other | 0.33% | -0.02% | — | |
| 46 | ADMA | Adma Biologics Inc | Stock-Healthcare | 0.32% | -0.32% | EXIT | |
| 47 | IBM | Intl Business Machines CORP | Stock-Tech | 0.31% | +0.01% | — | |
| 48 | ✓ | Biohaven Pharmaceutical Holding Co. Ltd | Stock-Other | 0.31% | -0.31% | EXIT | |
| 49 | PTHS | Pelthos Therapeutics Inc | Stock-Other | 0.26% | +0.07% | +9.29% | |
| 50 | KURA | Kura Oncology Inc | Stock-Other | 0.26% | +0.05% | +34.58% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-cl C | +2.3% | — | Unchanged |
| 2 | SNDX | Syndax Pharmaceuticals Inc | +1.8% | +1.69% | Add |
| 3 | AGIO | Agios Pharmaceuticals Inc | +1.6% | +416.99% | Add |
| 4 | ALKS | Alkermes plc | +1.3% | +26.32% | Add |
| 5 | TGTX | Tg Therapeutics Inc | +1.2% | +100.00% | Add |
| 6 | PTGX | Protagonist Therapeutics Inc | +1% | -13.70% | Trim |
| 7 | BBIO | Bridgebio Pharma Inc | +1% | +5.88% | Add |
| 8 | 260 | Centessa Pharmaceuticals-adr | +0.9% | +875.00% | Add |
| 9 | COGT | Cogent Biosciences Inc | +0.7% | +1.96% | Add |
| 10 | JAAA | Janus Henderson Aaa Clo ETF | +0.6% | — | Unchanged |
| 11 | ✓ | +0.6% | -24.39% | Trim | |
| 12 | JPM | Jpmorgan Chase & Co | +0.5% | — | Unchanged |
| 13 | XBI | Ss Spdr S&p Biotech ETF | +0.4% | +15.38% | Add |
| 14 | ✓ | Connect Biopharma Hldgs LTD | +0.3% | +93.92% | Add |
| 15 | RZLT | Rezolute Inc | +0.3% | +8.82% | Add |
| 16 | CNQ | Canadian Natural Resources | +0.2% | — | Unchanged |
| 17 | AB | Alliancebernstein Holding LP | +0.2% | — | Unchanged |
| 18 | RARE | Ultragenyx Pharmaceutical In | +0.2% | +65.30% | Add |
| 19 | PFE | Pfizer Inc | +0.2% | — | Unchanged |
| 20 | OBIO | Orchestra Biomed Holdings In | +0.2% | +1.46% | Add |
| 21 | CLOZ | Eldridge Bbb-b Clo ETF | +0.1% | — | Unchanged |
| 22 | XERS | Xeris Biopharma Holdings Inc | +0.1% | +9.28% | Add |
| 23 | IBB | Ishares Biotechnology ETF | +0.1% | — | Unchanged |
| 24 | MDGL | Madrigal Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 25 | AAPL | Apple Inc | +0.1% | — | Unchanged |
| 26 | KURA | Kura Oncology Inc | +0.1% | +34.58% | Add |
| 27 | JNJ | Johnson & Johnson | +0.1% | -28.89% | Trim |
| 28 | PWR | Quanta Services Inc | 0% | — | Unchanged |
| 29 | 6D8 | Dupont De Nemours Inc | 0% | — | Unchanged |
| 30 | MDLZ | Mondelez International Inc-a | 0% | — | Unchanged |
| 31 | KMB | Kimberly-clark CORP | 0% | — | Unchanged |
| 32 | VRDN | Viridian Therapeutics Inc | 0% | +24.83% | Add |
| 33 | IBM | Intl Business Machines CORP | 0% | — | Unchanged |
| 34 | AVGO | Broadcom Inc | 0% | — | Unchanged |
| 35 | DOW | Dow Inc | 0% | — | Unchanged |
| 36 | CTVA | Corteva Inc | 0% | — | Unchanged |
| 37 | NVDA | Nvidia CORP | 0% | — | Unchanged |
| 38 | EBC | Eastern Bankshares Inc | 0% | — | Unchanged |
| 39 | RHP | Ryman Hospitality Properties | 0% | — | Unchanged |
| 40 | VERA | Vera Therapeutics Inc | 0% | — | Unchanged |
| 41 | OXY | Occidental Petroleum CORP | 0% | — | Unchanged |
| 42 | ✓ | 0% | — | Unchanged | |
| 43 | AMZN | Amazon.com Inc | 0% | — | Unchanged |
| 44 | IWP | Ishares Russell Mid-cap Grow | 0% | — | Unchanged |
| 45 | LEGH | Legacy Housing CORP | 0% | — | Unchanged |
| 46 | MREO | Mereo Biopharma Group Pl-adr | — | — | Unchanged |
| 47 | DHR | Danaher CORP | — | — | Unchanged |
| 48 | URI | United Rentals Inc | — | — | Unchanged |
| 49 | CRM | Salesforce Inc | — | — | Unchanged |
| 50 | TMO | Thermo Fisher Scientific Inc | — | — | Unchanged |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 90 disclosed positions in Q1 2026.
During Q1 2026, Knott David M Jr's top holdings by market value included GOOG (15.6%)、APO (14.9%)、SNDX (5.9%). The largest single position, GOOG, represented 15.6% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
IOVA
市值: $5.6M
Top Position Liquidated / Trimmed
CLMT
前期市值: $44.0M
In Q1 2026, Knott David M Jr made 52 total portfolio adjustments, initiating 10 new buys, adding to 17 positions, trimming 13 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.